Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
None
Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

The primary objective of the study is to evaluate the efficacy of tislelizumab in participants with relapsed/refractory classical Hodgkin lymphoma, as measured by the overall response rate per

lymphoma
brentuximab
refractory classical hodgkin lymphoma
chemotherapy regimen
avid
  • 0 views
  • 22 Dec, 2021
  • 45 locations
None
Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma

The primary objective of this study is to evaluate the efficacy of tislelizumab in participants with relapsed or refractory classical Hodgkin lymphoma (cHL), as measured by Progression-free

  • 0 views
  • 12 Jan, 2022
  • 8 locations
None
Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

Survival (PFS) in participants with relapsed or refractory Classical Hodgkin Lymphoma compared to treatment with Chemotherapy.

  • 0 views
  • 15 Feb, 2021
  • 1 location
None
Itacitinib + Everolimus in Hodgkin Lymphoma

This is an open-label, single-group, Phase I/II study of itacitinib in combination with everolimus in subjects with relapsed or refractory classical Hodgkin lymphoma (cHL).

hysterectomy
carcinoma
gilbert's syndrome
platelet count
refractory classical hodgkin lymphoma
  • 1 views
  • 06 Aug, 2021
  • 1 location
None
BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant

A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with Brentuximab Vedotin-ESHAP vs ESHAP in Patients with Relapsed / Refractory Classical Hodgkin's Lymphoma, Followed by

  • 0 views
  • 27 Jan, 2021
  • 19 locations
None
Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

The aim of the trial is to improve disease control after an allogeneic stem cell transplantation (alloSCT) for relapsed or refractory classical Hodgkin lymphoma (rrHL, cHL) with consolidation

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

The primary objective of the study is to evaluate the objective response rate (ORR), by cohort, rrcHL and rrPMBCL, as assessed by the investigator according to Lugano classification criteria 2014 in participants treated with pembrolizumab Q6W.

lymphoma
brentuximab
  • 0 views
  • 19 Jan, 2022
  • 22 locations
None
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).

nivolumab
chemotherapy regimen
lymphoma
remission
refractory classical hodgkin lymphoma
  • 39 views
  • 25 Aug, 2021
  • 4 locations
None
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

This study is looking at the effects of Ipilimumab when it is given alone or in combination with Nivolumab to patients with relapsed or refractory classic Hodgkin's lymphoma (cHL). The names of the study drugs involved in this study are: Ipilimumab Nivolumab

cell transplantation
lymphoma
nivolumab
measurable disease
  • 0 views
  • 03 Oct, 2021
  • 3 locations
None
Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

This phase II trial studies how well umbralisib and pembrolizumab work in treating patients with classical Hodgkin lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Umbralisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with …

lymphoma
refractory classical hodgkin lymphoma
cancer
avid
classical hodgkin lymphoma
  • 0 views
  • 04 Sep, 2021
  • 1 location